A Multi-Centre, Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Explore Efficacy and Safety of Sevuparin Infusion for the Management of Acute VasoOcclusive Cvisis(VOC) in Subjects with Sickle-Cell Disease (SCD).